Ellevest Inc’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Ellevest Inc's BIIB Position: Q2 2026 in Review
Ellevest Inc reduced its Biogen (BIIB) stake by 9.5% in Q2 2026, selling an estimated $71.4K and leaving 3,573 shares worth $772K. The position accounts for 0.09% of the portfolio, ranked #162.
Ellevest Inc first reported a position in BIIB in Q3 2019 and has held it in 20 quarters since. The position peaked at $909K in Q4 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Ellevest Inc held 3,573 shares of Biogen worth $772K as of Q2 2026.
- Ellevest Inc sold 373 Biogen shares in Q2 2026, an estimated $71.4K.
- Biogen made up 0.09% of Ellevest Inc's portfolio in Q2 2026, its #162 holding.
- Ellevest Inc first reported a position in Biogen in Q3 2019 and has held it in 20 quarters since.
- Ellevest Inc's Biogen position peaked at $909K in Q4 2025.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.